Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.
about
Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired WeaknessRationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach UsKey mechanisms governing resolution of lung inflammationEfficacy of prone position in acute respiratory distress syndrome patients: A pathophysiology-based reviewThe acute respiratory distress syndromeMechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcomeUpdate on adrenal insufficiency in patients with liver cirrhosisClinical Practice Guideline of Acute Respiratory Distress SyndromeEffective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS.Diagnosis and treatment of children with severe influenza A from the 2009/2010 pandemic in Tianjin, China.Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection.Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic.Steroids for acute respiratory distress syndrome?Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis.Dexamethasone attenuates VEGF expression and inflammation but not barrier dysfunction in a murine model of ventilator-induced lung injury.Nasal potential difference to detect Na+ channel dysfunction in acute lung injury.The efficacy of systemic corticosteroids in treatment of respiratory tract infections during hajj 2012.The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes.Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress SyndromeAcute respiratory distress syndrome: pathophysiology and therapeutic optionsProlonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: Results from a double-blind, placebo-controlled randomized pilot trial.Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysisPlasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Year in review in Intensive Care Medicine, 2008: II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation.Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study.Revisiting steroid treatment for septic shock: molecular actions and clinical effects--a review.Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome.Corticosteroids and ARDS: A review of treatment and prevention evidenceUse of extracorporeal life support in adults with severe acute respiratory failure.Adjunctive treatments in pediatric acute respiratory distress syndrome.The pharmacology of acute lung injury in sepsis.Coupled plasma filtration adsorption for the treatment of a patient with acute respiratory distress syndrome and acute kidney injury: a case reportThe clinical practice guideline for the management of ARDS in Japan.Inhibition of endogenous glucocorticoid synthesis aggravates lung injury triggered by septic shock in rats.Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study.
P2860
Q26741099-FEC20A1A-2775-4EE9-9B8F-BA7F300ADCA1Q26744478-F408B806-6F91-44E3-A8C1-177F382A51BAQ26749606-74EDFF39-8CFD-4BE6-A96A-E5409672B50EQ26751602-C1F9CD63-0FE4-4FFA-907D-C270AFF97E1EQ26822697-A159CFCE-551D-451F-A33A-A3A5E5DB5E86Q27006565-FEC5333E-2A0F-4D2C-8A6E-78AD8607DE4EQ27008289-ACDBD450-C743-4E3F-82F6-5E7A7D4B60DEQ28074353-9880482C-3DDD-48CA-80D6-46CCA66DFFA7Q30252882-74045D21-7267-46B2-A2CA-D6E263C4DFD2Q30357785-D4CA30E9-9003-4F76-838D-E256B12666D5Q30381783-F9E3E8C2-C04D-4831-AD49-C929BD138EB5Q30396672-04E3FC13-6C37-44F0-BFFC-B37665839B73Q30410015-6112FCEA-1154-45C5-ABA2-25E606292806Q34451061-E586004A-188F-4BAA-8A39-E48D94415488Q34462425-E19A90C7-7B72-4B00-88C5-EC4D9697934AQ34603440-5637460D-4CBB-43CE-9AE3-269F8AD6E947Q34720193-D3B3A773-2DB7-4556-928C-A67A50348DAFQ35124284-548BD61C-ECE5-4836-B773-EA74F04E869EQ35151668-CC122234-266A-4F86-B5DD-35420D0C3950Q35652003-EDD6E5CF-AEB6-4A27-81AF-62356035A94EQ35757010-D99EAF61-4ABD-4A63-8AE2-19E97F2DCABBQ35823842-3E496090-2837-48CF-BD7F-D60B21E97E3CQ36338911-955C53B7-3100-49BF-8C3C-3B1F4C3FD59AQ36626228-475817C3-E63E-483F-9907-605D030B1B99Q36751000-946542FF-4196-4DD8-BC6D-1DD891AAA1D4Q37276584-822D9834-A88A-4EC3-AD47-12E195583733Q37363093-98ED6861-4514-4455-BE88-73A5FA0BD998Q37479567-298C8241-63A3-45DD-ABDE-137A782B7F56Q37590213-2D231ADD-F0AF-4E7D-8D0C-7AF8559968FBQ37631956-57BC23CB-EFD6-4D0E-8BF5-8417CB6EC592Q37734444-01346950-FACF-4580-B7B8-192D4056FE12Q37895462-BC0618F5-9593-4834-B1B9-34270DD1D20BQ37940006-D36ED2A2-7C7B-4FE5-966A-AC2C32A96C6FQ38239584-817C4056-9E02-4AE3-A662-998F20203939Q39731082-7338DF1B-0B73-492D-BE2F-0E01D8E47D41Q40339856-FDF91A95-4B25-47D7-9445-1AE0A9521B51Q41117178-7E14214E-92A7-498D-860F-F6E0989DEE37Q41494602-19F9117B-2D82-49D6-977E-9F0DA34CE1CEQ41685163-EECA9D9E-43FD-42E3-9316-D020B457AAD4Q42215030-25D2BFC2-A784-477A-9A08-E17C06E12397
P2860
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@en
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@nl
type
label
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@en
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@nl
prefLabel
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@en
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@nl
P2093
P50
P1476
Steroid treatment in ARDS: a c ...... ial and the recent literature.
@en
P2093
Albertus Beishuizen
Faran Bokhari
G Umberto Meduri
Gary Zaloga
George P Chrousos
P2860
P2888
P356
10.1007/S00134-007-0933-3
P577
2007-11-14T00:00:00Z